Every CVE Search/ Get API key

CVE-2025-0416

Valmet DNA Local privilege escalation through insecure DCOM configuration

8.9 High

Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.

Attack profile

How easy it is to exploit

Attack vector
Adjacent network
Complexity
Low
Privileges needed
Low
User interaction
None

What an attacker can affect

Confidentiality
High
Integrity
High
Availability
High

Exploit likelihood

0.21%Up 0.2 points since Apr 1, 2025
90%50%10%1%

What each source reports

CVE List Score used 8.9

Valmet DNA Local privilege escalation through insecure DCOM configuration

Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.

Record
CVE-2025-0416
CVSS 4.0
8.9 HighCVSS:4.0/AV:A/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/S:N/AU:Y/R:U/V:D/RE:H/U:Amber
Weakness
CWE-250
Updated
2026-11-02
EUVDEUVD-2025-9126 8.9

Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.

Record
EUVD-2025-9126
CVSS 4.0
8.9 HighCVSS:4.0/AV:A/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/S:N/AU:Y/R:U/V:D/RE:H/U:Amber
Updated
2026-11-02
GitHub AdvisoriesGHSA-23pg-v644-m29h 8.9

Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to...

Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.

Record
GHSA-23pg-v644-m29h
CVSS 4.0
8.9 HighCVSS:4.0/AV:A/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:Y/R:U/V:D/RE:H/U:Amber
Weakness
CWE-269
Updated
2026-11-02
NVD 8.9

Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.

Record
CVE-2025-0416
CVSS 4.0
8.9 HighCVSS:4.0/AV:A/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:Y/R:U/V:D/RE:H/U:Amber
Weakness
CWE-250
Updated
2026-11-02

Affected products

History

History
RecordedChangedSources
first indexedCVE List, EUVD, GitHub Advisories, NVD

Dates are when Every CVE recorded each change. Upstream dates may differ.

In short

CVE-2025-0416 is a high vulnerability (CVSS 8.9) in Valmet Dna, published April 1, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.21%, the 11th percentile. No source names a fixed version.

References

MoveEnter Open